International Journal of Colorectal Disease

, Volume 22, Issue 8, pp 911–917 | Cite as

Isolated tumor cell in lateral lymph node has no influences on the prognosis of rectal cancer patients

  • M. Hara
  • T. Hirai
  • H. Nakanishi
  • Y. Kanemitsu
  • K. Komori
  • M. Tatematsu
  • T. Kato
Original Article


Background and aims

The aim of this study was to determine the incidence of isolated tumor cells (ITC) and micrometastasis in lateral lymph nodes of patients with rectal cancer and its possible correlation with prognosis.

Materials and methods

One hundred seventy-seven rectal cancer patients who underwent curative resection with lateral lymph node dissection were enrolled. Dissected lymph nodes were examined using hematoxylin–eosin staining (HE) and immunohistochemistry (IHC) with anti-keratin antibody (AE1/AE3). States of lymph node metastasis were divisible into three groups: detectable with HE (HE+), detectable with only IHC (HE−/IHC+), and undetectable even with IHC (IHC−). Almost all the HE−/IHC+ group was classified as ITC consisting of a few tumor cells according to the UICC criteria (ITC+). Survival rates were compared among HE+, ITC+, and IHC−.


ITC+ were detected in 24.1% of patients with HE-negative lateral lymph nodes. No significant difference in overall 5-year survival was observed between ITC+ and IHC− patients (76.1 and 82.9%, respectively, p = 0.25). Multivariate analysis showed that perirectal HE+ lymph nodes, but not ITC+ lateral lymph nodes, was an independent prognostic factor.


ITC in lateral lymph nodes does not contribute to the prognosis of rectal cancer in patients who undergo extended lateral lymph node dissection, unlike HE+ lateral lymph node metastasis.


Rectal cancer Lateral lymph node metastasis Isolated tumor cell Immunohistochemistry Lateral lymph node dissection 



The authors thank Mrs. H. Ban for expert technical assistance.


  1. 1.
    Creasman WT, DeGeest K, DiSaia PJ, Zaino RJ (1999) Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. Am J Obstet Gynecol 181:31–34PubMedCrossRefGoogle Scholar
  2. 2.
    Bochner BH, Herr HW, Reuter VE (2001) Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 166:2295–2296PubMedCrossRefGoogle Scholar
  3. 3.
    Heidenreich A, Varga Z, Von Knobloch R (2002) Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167:1681–1686PubMedCrossRefGoogle Scholar
  4. 4.
    Bacon HE, Sauer I (1950) Surgical treatment of cancer of the lower bowel. Cancer 3:773–778PubMedCrossRefGoogle Scholar
  5. 5.
    Stearns MW Jr, Deddish MR (1959) Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum. Dis Colon Rectum 2:169–172PubMedCrossRefGoogle Scholar
  6. 6.
    Havenga K, Enker WE, Norstein J, Moriya Y, Heald RJ, van Houwelingen HC, van de Velde CJ (1999) Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol 25:368–374PubMedCrossRefGoogle Scholar
  7. 7.
    Carlsen E, Schlichting E, Guldvog I, Johnson E, Heald RJ (1998) Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 85:526–529PubMedCrossRefGoogle Scholar
  8. 8.
    MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341:457–460PubMedCrossRefGoogle Scholar
  9. 9.
    Delaney CP, Lavery IC, Brenner A, Hammel J, Senagore AJ, Noone RB, Fazio VW (2002) Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers. Ann Surg 236:203–207PubMedCrossRefGoogle Scholar
  10. 10.
    Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646PubMedCrossRefGoogle Scholar
  11. 11.
    Bonnel C, Parc YR, Pocard M, Dehni N, Caplin S, Parc R, Tiret E (2002) Effects of preoperative radiotherapy for primary resectable rectal adenocarcinoma on male sexual and urinary function. Dis Colon Rectum 45:934–939PubMedCrossRefGoogle Scholar
  12. 12.
    Koyama Y, Moriya Y, Hojo K (1984) Effects of extended systematic lymphadenectomy for adenocarcinoma of the rectum-significant improvement of survival rate and decrease of local recurrence. Jpn J Clin Oncol 14:623–632PubMedGoogle Scholar
  13. 13.
    Sugihara K, Moriya Y, Akasu T, Fujita S (1996) Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome. Cancer 78:1871–1880PubMedCrossRefGoogle Scholar
  14. 14.
    Mori T, Takahashi K, Yasuno M (1998) Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbecks Arch Surg 383:409–415PubMedCrossRefGoogle Scholar
  15. 15.
    Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73:563–569PubMedCrossRefGoogle Scholar
  16. 16.
    Broll R, Schauer V, Schimmelpenning H, Strik M, Woltmann A, Best R, Bruch HP, Duchrow M (1997) Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study. Dis Colon Rectum 40:1465–1471PubMedCrossRefGoogle Scholar
  17. 17.
    Isaka N, Nozue M, Doy M, Fukao K (1999) Prognostic significance of perirectal lymph node micrometastases in Dukes’ B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 5:2065–2068PubMedGoogle Scholar
  18. 18.
    Jeffers MD, O’Dowd GM, Mulcahy H, Stagg M, O’Donoghue DP, Toner M (1994) The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 172:183–187PubMedCrossRefGoogle Scholar
  19. 19.
    Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L (1996) Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes’ B colorectal carcinoma: an immunohistochemical study. Eur J Surg 162:637–642PubMedGoogle Scholar
  20. 20.
    Cutait R, Alves VA, Lopes LC, Cutait DE, Borges JL, Singer J, da Silva JH, Goffi FS (1991) Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34:917–920PubMedCrossRefGoogle Scholar
  21. 21.
    Shimoyama M, Yamazaki T, Suda T, Hatakeyama K (2003) Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5.2. Dis Colon Rectum 46:333–339PubMedCrossRefGoogle Scholar
  22. 22.
    Sobin LH (2003) TNM: evolution and relation to other prognostic factors. Sem Surg Oncol 21:3–7CrossRefGoogle Scholar
  23. 23.
    Sobin LH (2003) TNM, sixth edition: new developments in general concepts and rules. Sem Surg Oncol 21:19–22CrossRefGoogle Scholar
  24. 24.
    Hermanek P, Hutter RV, Sobin LH, Wittekind C (1999) International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 86:2668–2673PubMedCrossRefGoogle Scholar
  25. 25.
    Sobin LH, Wittekind C (2002) TNM classification of malignant tumors, 6th edn. Wiley, New YorkGoogle Scholar
  26. 26.
    Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S (2001) Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 8:300–304PubMedCrossRefGoogle Scholar
  27. 27.
    Tepper JE, O’Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson AB 3rd, Cummings B, Gunderson L, Macdonald JS, Mayer RJ (2001) Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19:157–163PubMedGoogle Scholar
  28. 28.
    Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17:2896–2900PubMedGoogle Scholar
  29. 29.
    Moriya Y, Hojo K, Sawada T, Koyama Y (1989) Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 32:307–315PubMedCrossRefGoogle Scholar
  30. 30.
    Fujita S, Yamamoto S, Akasu T, Moriya Y (2003) Lateral pelvic lymph node dissection for advanced lower rectal cancer. Br J Surg 90:1580–1585PubMedCrossRefGoogle Scholar
  31. 31.
    Greene FL, Page D, Fleming ID (2002) AJCC Cancer staging manual, 6th edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
  32. 32.
    Enker WE, Thaler HT, Cranor ML, Polyak T (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335–346PubMedGoogle Scholar
  33. 33.
    (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators. Lancet 345:939–944Google Scholar
  34. 34.
    Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, Jones J, Mamounas EP, Ore L, Petrelli NJ et al (1993) The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 11:1879–1887PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • M. Hara
    • 1
    • 2
  • T. Hirai
    • 1
  • H. Nakanishi
    • 2
  • Y. Kanemitsu
    • 1
  • K. Komori
    • 1
  • M. Tatematsu
    • 2
  • T. Kato
    • 1
  1. 1.Department of Gastroenterological SurgeryAichi Cancer Center HospitalNagoya, AichiJapan
  2. 2.Division of Oncological PathologyAichi Cancer Center Research InstituteAichiJapan

Personalised recommendations